ARK Innovation ETF vs Heron Therapeutics Inc — how do they compare? ARK Innovation ETF trades at $81.38, while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: ARK Innovation ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| ARKK | HRTX | |
|---|---|---|
52-Week High | $92.50 | $1.49 |
52-Week Low | $63.52 | $0.32 |
Market Cap | — | $61.47M |
Sector | — | Health |
Enterprise Value | — | $168.21M |
Trailing returns across standard periods
Latest headlines on both assets
The fund will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund’s investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund may invest in foreign securities listed on foreign exchanges as well as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The fund is non-diversified.
Read more on ARKK →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →